Editor’s note: The drugs are listed in alphabetical order.
1. Betamethasone acetate and betamethasone sodium phosphate suspension: This injectable corticosteroid is available in certain dosages in limited quantities. Two main producers reporting shortages are American Regent and Organon, neither of which provided a reason for the shortage.
2. Cisatracurium besylate injections: AbbVie discontinued three solutions of the muscle relaxers used before and during surgery.
3. Copper chloride injections: Pfizer is facing a shortage of this drug, typically used as an additive to intravenous solutions, which it attributes to manufacturing delays. The company has a limited supply of vials available for direct order only in the case of emergency.
4. Hydroxocobalamin intramuscular solutions: Teva reported a shortage of multiple dosages of this drug, typically used to treat vitamin B12 deficiencies. It has vials on back order and estimates a restock in mid-November.
5. Levofloxacin oral solutions: Lanet has reported a shortage of multiple dosages of this medication used to treat bacterial infections. Oral tablets are still available, but the manufacturer is unable to estimate a restock date.
6. Vinblastine sulfate injections: This cancer medication’s 10 milliliter vials are back ordered, according to Fresenius Kabi, the manufacturer. It estimates a resupply in late September.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
